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Abstract: We recruited 560 unrelated patients with ischemic stroke and 153 unrelated controls 
to undertake a genetic analysis for association between the NOS3 gene and ischemic stroke. All 
the subjects were Chinese of Han descent. Because the NOS3 gene spans about 21 kb of DNA 
and contains 26 exons, we selected a single nucleotide polymorphism (SNP) rs3918181, an 
A to G base change located in intron 14 of the gene, as a DNA marker. PCR-based restriction 
fragment length polymorphism analysis was applied to genotype rs3918181 (RsaI site). The 
chi-square (χ2) goodness-of-ﬁ  t test showed that the genotypic distributions of the marker 
were not deviated from Hardy-Weinberg equilibrium in both the patient group (χ2 = 0.166, 
p = 0.684) and the control group (χ2 = 0.421, p = 0.517). The cocaphase analysis showed allelic 
association of rs3918181 with ischemic stroke in males (χ2 = 4.04, p = 0.044, OR = 1.43, 95% 
CI 1.01∼2.02) and frequency of allele A was signiﬁ  cantly higher in male patients than male 
control subjects. The χ2 test revealed genotypic association between rs3918181 and ischemic 
stroke in males (χ2 = 4.26, df = 1, p = 0.039, OR = 1.61, 95% CI 1.02∼2.53) but not in females. 
The present work suggests that rs3918181 is associated with ischemic stroke in male patients. 
This ﬁ  nding gives further evidence in support of the eNOS association with ischemic stroke 
in the Chinese population.
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Introduction
Nitric oxide (NO) is known to have several important vasculo-protective effects 
(El-Mas et al 1997; Gürdal et al 2005). Reduced production of NO may lead to 
atherosclerosis (Lüscher and Vanhoutte 1990; Harrison 1997; Shimokawa 1999). 
The synthesis of NO from the amino acid, L-arginine, is catalysed by NO synthase 
(NOS). NO then plays a critical role in the relaxation of vascular smooth muscle cells 
(VSMCs). It is well known that NO is involved in reducing VSMC proliferation, 
adhesion of platelets and leukocytes (Moncada and Higgs 1993; Draijer et al 1995; 
Myers and Tanner 1998; Brocq et al 2008). NO is likely, therefore, to be an important 
contributory factor in the pathogenesis of some forms of stroke.
There are 3 distinct isoforms of NOS identiﬁ  ed in humans: endothelial (eNOS), neu-
ronal NOS (nNOS) and inducible NOS (iNOS). eNOS is a highly regulated isoform that 
is expressed primarily in endothelial cells. It synthesizes very low levels NO under basal 
conditions (Lüscher and Vanhoutte 1990; Harrison 1997; Shimokawa 1999). Because 
eNOS plays a central role in the maintenance of vascular homeostasis, including regula-
tion of the cerebral circulation, a number of studies have been conducted to investigate 
the genetic association between the eNOS gene and the incidence of ischemic stroke. 
Howard and colleagues (2005) detected 3 single nucleotide polymorphisms (SNPs) 
in the promoter region, 1 in exon 7 (G894T) and 1 insertion/deletion polymorphism 
within intron 4 among 110 cases with ischemic stroke and 206 controls. They found 
strong associations of both the −922 G-A and −786 T-C SNPs with ischemic stroke. International Journal of General Medicine 2008: 1 66
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Hou and colleagues (2001) were the ﬁ  rst to report the genetic 
association between the eNOS gene and ischemic stroke in 
a Chinese population and a recent work has conﬁ  rmed the 
intial ﬁ  nding (Berger et al 2007) although the eNOS associa-
tion failed to be replicated in a Japanese population (Yahashi 
et al 1998). This study might have been hampered by poor 
replication, a common problem with genetic analysis. Link-
age disequilibrium (LD) structure and sample power may be 
one of major reasons for poor replication of an initial ﬁ  nding. 
Therefore, the present study was designed to apply a large 
sample size to investigate genetic association between the 
eNOS gene and ischemic stroke.
Materials and methods
The present study recruited 560 unrelated patients with 
ischemic stroke and 153 unrelated controls in order to under-
take a genetic analysis for association between the NOS3 
gene and ischemic stroke. All the subjects used for this 
study were Chinese of Han descent. Patients with ischemic 
stroke were admitted to the First Hospital of Jilin University, 
Changchun, China in the period between 2005 and 2006. They 
were diagnosed as having ischemic stroke independently by at 
least two well-trained neurologists based on strict neurological 
examination, computed tomography, or magnetic resonance 
imaging, which meet the International Classiﬁ  cation of 
Diseases (NCHS 2007). Detailed information regarding their 
medical history, medication and clinical presentation was 
taken through either their close relatives or themselves. Of 
these 560 patients (398 males and 162 females), 426 were suf-
fering from simple lacunar infarction, 246 from large-vessel 
infarction and 112 from both. Those with hemorrhagic stroke 
were not included in this study. The general information of 
the subjects recruited is given in Table 1.
All the subjects gave written informed consent for the 
genetic analysis. The whole blood sample was taken from 
them for extraction of genomic DNA. The study was granted 
prior approval by the ethics committee of Jilin University, 
Changchun, China.
To perform genetic analysis, we selected SNP rs3918181 
(Rsa I site) as a genetic marker at the NOS3 locus. It is 
an A to G base change present in intron 14 of the gene. 
Polymerase chain reaction (PCR)-based restriction fragment 
length polymorphism (RFLP) analysis was performed to 
genotype rs3918181. Genomic DNA used for PCR ampliﬁ  ca-
tion was extracted from the whole blood sample using a DNA 
extraction kit (Promega, Beijing, China). PCR ampliﬁ  cation 
was performed in a 25-μl reaction volume containing 10 mM 
Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.001% 
(w/v) gelatin, 200 μM of each dNTP, 0.4 μM of each primer, 
1.0 unit of Taq DNA polymerase (Promega, Beijing, China), 
and 30–50 ng of genomic DNA. The conditions used for PCR 
ampliﬁ  cation included an initial denaturation at 94 ºC for 
5 min, followed by 35–40 cycles of 94 ºC for 45s, 55–60 ºC 
for 1 min and 72 ºC for 1 min, and a ﬁ  nal elongation at 
72 ºC for 10 min. A 15-μl aliquot of the PCR products was 
completely digested with 6–8 units of restriction enzymes. 
The digested PCR products were then separated on ethidium 
bromide-stained agarose gels.
The Hardy-Weinberg equilibrium for the genotypic 
distributions of rs3918181 was tested using the chi-square 
(χ2) goodness-of-ﬁ  t test. Applied to test sample power for 
individual alleles was tested using the SPSS SamplePower 
2.0 software package (SPSS Inc., Chicago, IL, USA). The 
signiﬁ  cance level was be set at 5% (two-tailed). Allelic 
association was tested by the COCAPHASE module of the 
UNPHASED program (Dudbridge 2003) and genotypic 
association was tested by the SPSS program for windows 
15.0 (SPSS Inc.).
Results
The χ2 goodness-of-ﬁ  t test showed that the genotypic distribu-
tions of rs3918181 were not deviated from Hardy-Weinberg 
Table 1 The general information of patients and controls
Patients with ischemic stroke
Controls (n = 153) Large-vessel (n = 246) Lacunar (n = 426) Mixed (n = 112)
Age (y) 55.6 ± 5.7 58.2 ± 12.4 60.5 ± 10.8 60.4 ± 11.5
Men 93 170 303 75
BMI (kg/m2) 24.9 ± 3.3 24.3 ± 3.2 25.1 ± 3.6 24.8 ± 3.6
History of hypertension 45 152 301 79
History of diabetes 16 44 80 21
History of heart disease 19 32 60 12
History of smoking 22 86 141 36International Journal of General Medicine 2008: 1 67
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equilibrium in both the patient group (χ2 = 0.166, p = 0.684) 
and the control group (χ2 = 0.421, p = 0.517). These 560 case 
and 153 control samples gave a power of 60% for detection 
of small effect size and 100% for detection of medium effect 
size. Analysis with the COCAPHASE program showed that 
rs3918181 was associated with ischemic stroke in males 
(χ2 = 4.04, p = 0.044, OR = 1.43, 95%CI 1.01∼2.02) and 
frequency of allele A of rs3918181 was signiﬁ  cantly higher in 
male patients than male control subjects (Table 2). However, 
female patients did not show such an association (Table 2). 
As shown in Table 3, the χ2 test revealed genotypic asso-
ciation between rs3918181 and ischemic stroke in males 
(X2 = 4.26, df = 1, p = 0.039, OR = 1.61, 95% CI 1.02∼2.53) 
but not the genotypic association was not observed in female 
subjects.
Discussion
The gene coding for eNOS is mapped to the long arm of 
chromosome 7 (7q36) and spans ∼21 kb of DNA, although 
it contains 26 exons. It should be sufﬁ  cient to capture a 
linkage disequilibrium (LD) signal by genotyping a highly 
polymorphic DNA marker present in the middle of the gene. 
SNP rs3918181 is located in intron 14 of the gene and has 
heterozygosity of 0.43. It may be an ideal DNA marker for 
association studies in a Chinese population.
The present work showed that rs3918181 was associated 
with ischemic stroke in male patients. This ﬁ  nding gives 
further evidence in support of the eNOS association with 
ischemic stroke in the Chinese population, although female 
patients did not show such an association in our samples 
(Tables 2 and 3). It is worth investigating the gender differ-
ences with more samples in a further study.
We recruited a total of 153 control subjects in this 
study. The sample power test indicates that the study is 
not sufﬁ  ciently powered at present for detection of small 
effect-size gene. However, we will continue to collect con-
trols matched for age, sex and ethnicity in order to conﬁ  rm 
the results and 80% of power will be needed for combined 
samples in our future study.
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